File size: 14,523 Bytes
06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 be415c5 06adf10 e0128c0 06adf10 be415c5 06adf10 |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 |
[
{
"id": "AITX-00001",
"patient": {
"genotype": [
{
"gene": "DMD",
"transcript": "NM_004006.2",
"variant_cdna": "c.7544_9286del",
"variant_protein": "p.(Thr2516_Ala3096del)",
"zygosity": "hemizygous"
}
],
"clinical_context": "Progressive muscle weakness"
},
"question": {
"category": "Established_Targeted",
"answer_format": "multiple_choice",
"prompt": "To which of the following targeted therapies would this variant be most likely amenable: Golodirsen, Viltolarsen, Eteplirsen, Casimersen, Ataluren, or None?",
"date_submitted": "2025-08-01"
},
"answer_expected": "Eteplirsen",
"answer_explanation": "Variant results in deletion of exons 52-63, which is listed as amenable to exon 51 skipping",
"difficulty_rationale": "",
"sources": ["GeneReviews", "PubMed/Literature"],
"citations": []
},
{
"id": "AITX-00002",
"patient": {
"genotype": [
{
"gene": "DMD",
"transcript": "NM_004006.2",
"variant_cdna": "c.10453_10454delinsTA",
"variant_protein": "p.(Leu3485Ter)",
"zygosity": "hemizygous"
}
],
"clinical_context": "Progressive muscle weakness"
},
"question": {
"category": "Established_Targeted",
"answer_format": "multiple_choice",
"prompt": "To which of the following targeted therapies would this variant be most likely amenable: Golodirsen, Viltolarsen, Eteplirsen, Casimersen, Ataluren, or None?",
"date_submitted": "2025-08-01"
},
"answer_expected": "Ataluren",
"answer_explanation": "Variant results in a nonsense in exon 74, which is amenable to nonsense readthrough",
"difficulty_rationale": "",
"sources": [],
"citations": []
},
{
"id": "AITX-00003",
"patient": {
"genotype": [
{
"gene": "DMD",
"transcript": "NM_004006.2",
"variant_cdna": "c.70T>C",
"variant_protein": "p.(Trp24Arg)",
"zygosity": "hemizygous"
}
],
"clinical_context": "Progressive muscle weakness"
},
"question": {
"category": "Established_Targeted",
"answer_format": "multiple_choice",
"prompt": "To which of the following targeted therapies would this variant be most likely amenable: Eteplirsen, Golodirsen, Viltolarsen, Casimersen, Ataluren, or None?",
"date_submitted": "2025-08-01"
},
"answer_expected": "None",
"answer_explanation": "Results in a missense in exon 2, which is not amenable to nonsense readthrough and is upstream from skippable exons",
"difficulty_rationale": "",
"sources": [],
"citations": []
},
{
"id": "AITX-00004",
"patient": {
"genotype": [
{
"gene": "AGXT",
"transcript": "NM_000030.3",
"variant_cdna": "c.508G>A",
"variant_protein": "p.(Gly170Arg)",
"zygosity": "homozygous"
}
],
"clinical_context": "Recurrent nephrocalcinosis and chronic kidney disease"
},
"question": {
"category": "Established_Targeted",
"answer_format": "string_match",
"prompt": "What targeted, small molecule therapy is available for this patient? Provide the generic name or None.",
"date_submitted": "2025-08-01"
},
"answer_expected": "Pyridoxine",
"answer_explanation": "Missense variants are amenable to pyridoxine treatment",
"difficulty_rationale": "",
"sources": ["GeneReviews"],
"citations": ["https://www.ncbi.nlm.nih.gov/books/NBK1283/"]
},
{
"id": "AITX-00005",
"patient": {
"genotype": [
{
"gene": "AGXT",
"transcript": "NM_000030.3",
"variant_cdna": "c.33dup",
"variant_protein": "p.(Lys12GlnfsTer156)",
"zygosity": "homozygous"
}
],
"clinical_context": "Recurrent nephrocalcinosis and chronic kidney disease"
},
"question": {
"category": "Established_Targeted",
"answer_format": "binary",
"prompt": "Is this patient predicted to be responsive to pyridoxine? Answer yes or no.",
"date_submitted": "2025-08-01"
},
"answer_expected": "No",
"answer_explanation": "Pyridoxine is not effective for patients with null variants",
"difficulty_rationale": "",
"sources": ["GeneReviews"],
"citations": ["https://www.ncbi.nlm.nih.gov/books/NBK1283/"]
},
{
"id": "AITX-00006",
"patient": {
"genotype": [
{
"gene": "AGXT",
"transcript": "NM_000030.3",
"variant_cdna": "c.33dup",
"variant_protein": "p.(Lys12GlnfsTer156)",
"zygosity": "homozygous"
}
],
"clinical_context": "7 year old with recurrent nephrocalcinosis and chronic kidney disease"
},
"question": {
"category": "Established_Targeted",
"answer_format": "string_match",
"prompt": "What targeted, genetic therapies are approved for this patient in the US? Provide the generic name.",
"date_submitted": "2025-08-01"
},
"answer_expected": "Lumasiran",
"answer_explanation": "Lumasiran is approved for patients of all ages whereas Nedosiran is only approved for patients age >9.",
"difficulty_rationale": "slight change in patient age changes the answer",
"sources": ["GeneReviews"],
"citations": ["https://www.ncbi.nlm.nih.gov/books/NBK1283/"]
},
{
"id": "AITX-00007",
"patient": {
"genotype": [
{
"gene": "DDC",
"transcript": "NM_001082971.2",
"variant_cdna": "c.286G>A",
"variant_protein": "p.(Gly96Arg)",
"zygosity": "homozygous"
}
],
"clinical_context": "Global developmental delay"
},
"question": {
"category": "Established_Targeted",
"answer_format": "string_match",
"prompt": "What is the youngest age for which a gene therapy is approved for this patient's genetic condition in the united kingdom? Answer with the format \"X months\".",
"date_submitted": "2025-08-01"
},
"answer_expected": "18 months",
"answer_explanation": "specified on GeneReviews",
"difficulty_rationale": "",
"sources": ["GeneReviews"],
"citations": ["https://www.ncbi.nlm.nih.gov/books/NBK595821/"]
},
{
"id": "AITX-00008",
"patient": {
"genotype": [
{
"gene": "COL1A1",
"transcript": "NM_000088.4",
"variant_cdna": "c.1678G>A",
"variant_protein": "p.(Gly560Ser)",
"zygosity": "heterozygous"
}
],
"clinical_context": "joint hypermobility, skin hyperextensibility, and easy bruising"
},
"question": {
"category": "Established_Supportive",
"answer_format": "string_match",
"prompt": "What two medications are most established for decreasing bruising? List generic names in alphabetical order",
"date_submitted": "2025-08-01"
},
"answer_expected": "ascorbic acid, desmopressin",
"answer_explanation": "specified in management on GeneReviews",
"difficulty_rationale": "",
"sources": ["GeneReviews"],
"citations": ["https://www.ncbi.nlm.nih.gov/books/NBK1244/#eds.Management"]
},
{
"id": "AITX-00009",
"patient": {
"genotype": [
{
"gene": "SLC35A2",
"transcript": "NM_005660.3",
"variant_cdna": "c.3G>A",
"variant_protein": "p.Met1Ile",
"zygosity": "heterozygous"
}
],
"clinical_context": "Patient with SLC35A2-CDG who is experiencing seizures and global developmental delay"
},
"question": {
"category": "Clinical_Trials",
"answer_format": "string_match",
"prompt": "What clinical trial developing a new therapeutic for this condition is recruiting or listed as upcoming/not yet recruiting? Return a clinical trials ID",
"date_submitted": "2025-08-01"
},
"answer_expected": "NCT05402384",
"answer_explanation": "search for SLC35A2 on ClinicalTrials.gov returns only 2 trials, 1 of which is upcoming",
"difficulty_rationale": "",
"sources": ["ClinicalTrials.gov"],
"citations": ["https://clinicaltrials.gov/study/NCT05402384"]
},
{
"id": "AITX-00010",
"patient": {
"genotype": [
{
"gene": "SLC35A2",
"transcript": "NM_005660.3",
"variant_cdna": "c.3G>A",
"variant_protein": "p.Met1Ile",
"zygosity": "heterozygous"
}
],
"clinical_context": "seizures and global developmental delay. Age 2 months, Hemoglobin 5, Normal liver labs, Not enrolled in other trials"
},
"question": {
"category": "Clinical_Trials",
"answer_format": "binary",
"prompt": "Is this patient eligible for clinical trial NCT05402384? Answer yes or no.",
"date_submitted": "2025-08-01"
},
"answer_expected": "No",
"answer_explanation": "Exclusion criteria lists hemoglobin <7",
"difficulty_rationale": "",
"sources": ["ClinicalTrials.gov"],
"citations": ["https://clinicaltrials.gov/study/NCT05402384"]
},
{
"id": "AITX-00011",
"patient": {
"genotype": [
{
"gene": "KCNT1",
"transcript": "NM_020822.3",
"variant_cdna": "c.2849G>A",
"variant_protein": "p.Arg950Gln",
"zygosity": "heterozygous"
}
],
"clinical_context": "early-onset seizures and developmental delays"
},
"question": {
"category": "Clinical_Trials",
"answer_format": "string_match",
"prompt": "For which clinical trials evaluating new therapeutics is this patient eligible? Provide a clinical trial ID or answer None.",
"date_submitted": "2025-08-01"
},
"answer_expected": "None",
"answer_explanation": "Only a natural history study is listed.",
"difficulty_rationale": "",
"sources": ["ClinicalTrials.gov"],
"citations": ["https://clinicaltrials.gov/search?cond=KCNT1"]
},
{
"id": "AITX-00012",
"patient": {
"genotype": [
{
"gene": "GRIN2B",
"transcript": "NM_000834.5",
"variant_cdna": "c.2755C>T",
"variant_protein": "p.Gln919Ter",
"zygosity": "heterozygous"
}
],
"clinical_context": "intellectual disability, seizures, and developmental delays"
},
"question": {
"category": "Drug_Development_and_Repurposing",
"answer_format": "multiple_choice",
"prompt": "Is it more likely amenable to treatment with Memantine, L-serine, or Radiprodil",
"date_submitted": "2025-08-01"
},
"answer_expected": "L-Serine",
"answer_explanation": "Variant is a LOF variant. L-serine is being used for LOF variants whereas the others are being used for GOF variants",
"difficulty_rationale": "",
"sources": ["PubMed/Literature"],
"citations": ["https://academic.oup.com/brain/article/147/5/1653/7611854?login=false"]
},
{
"id": "AITX-00013",
"patient": {
"genotype": [
{
"gene": "ANO10",
"transcript": "NM_018075.5",
"variant_cdna": "c.289del",
"variant_protein": "p.(Met97Ter)",
"zygosity": "homozygous"
}
],
"clinical_context": "progressive cerebellar ataxia and peripheral neuropathy"
},
"question": {
"category": "Variant_Assessment",
"answer_format": "numeric_match",
"prompt": "How many amino acids are coded for by the exon in which this variant occurs? Answer with a number",
"date_submitted": "2025-08-01"
},
"answer_expected": "66",
"answer_explanation": "visual inspection on Ensembl",
"difficulty_rationale": "",
"sources": ["Other"],
"otherSource": "Ensembl",
"citations": []
},
{
"id": "AITX-00014",
"patient": {
"genotype": [
{
"gene": "ANO10",
"transcript": "NM_018075.5",
"variant_cdna": "c.289del",
"variant_protein": "p.(Met97Ter)",
"zygosity": "homozygous"
}
],
"clinical_context": "progressive cerebellar ataxia and peripheral neuropathy"
},
"question": {
"category": "Variant_Assessment",
"answer_format": "numeric_match",
"prompt": "What percentage of the total coding transcript for this gene are encoded by the exon in which this variant occurs? Answer with a decimal to nearest tenth.",
"date_submitted": "2025-08-01"
},
"answer_expected": "0.1",
"answer_explanation": "66/660 = 0.1",
"difficulty_rationale": "",
"sources": ["Other"],
"otherSource": "Ensembl",
"citations": []
},
{
"id": "AITX-00015",
"patient": {
"genotype": [
{
"gene": "KMT2B",
"transcript": "NM_014727.3",
"variant_cdna": "c.8079delC",
"variant_protein": "p.(Ile2694SerfsTer44)",
"zygosity": "heterozygous"
}
],
"clinical_context": "childhood-onset generalized dystonia"
},
"question": {
"category": "Variant_Assessment",
"answer_format": "binary",
"prompt": "Based on typical prediction rules, is this variant likely to result in nonsense mediated decay? Answer yes or no.",
"date_submitted": "2025-08-01"
},
"answer_expected": "No",
"answer_explanation": "At the end of the last exon, after the main domain",
"difficulty_rationale": "",
"sources": ["Other"],
"otherSource": "Ensembl",
"citations": []
},
{
"id": "AITX-00016",
"patient": {
"genotype": [
{
"gene": "NF1",
"transcript": "NM_001042492.3",
"variant_cdna": "c.3728T>C",
"variant_protein": "p.(Leu1243Pro)",
"zygosity": "heterozygous"
}
],
"clinical_context": "Malignant Peripheral Nerve Sheath Tumor and Pheochromocytoma"
},
"question": {
"category": "Variant_Assessment",
"answer_format": "multiple_choice",
"prompt": "In which functional domain does this variant occur? Answer choices: CSRD, TBD, GRD, Sec14-PH, HLR, NLS, SBR.",
"date_submitted": "2025-08-01"
},
"answer_expected": "GRD",
"answer_explanation": "GRD, GAP related domain (1198–1549 residues)",
"difficulty_rationale": "",
"sources": ["PubMed/Literature"],
"citations": ["https://www.mdpi.com/2073-4425/13/7/1130#"]
}
] |